The potential of oligonucleotide submicron positively charged emulsion ocular delivery system for age related macular degeneration

Project Information

ARMD

Grant agreement ID: QLK6-CT-2002-71584

Project closed

Start date 1 January 2003

End date 31 January 2005

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 1 617 600,00

EU contribution € 808 600,00

Coordinated by

NOVAGALI PHARMA SA
France

Fields of science

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

• medical and health sciences › clinical medicine › ophthalmology

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Call for proposal

Data not available

Funding Scheme

CRS - Cooperative research contracts

Coordinator

NOVAGALI PHARMA SA

• EU contribution: No data
• Address: Rue Pierre Fontaine 1 ; 91000 EVRY ; France
• Total cost: No data

Participants (3)

CORALTIS LTD

Israel

• EU contribution: No data
• Address: Hamlaha St, 22 Park cible Rosh Ha Ayin ; 48091 ZIP
• Total cost: No data

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

• EU contribution: No data
• Address: Rue de l'Ecole de Medecine, 15 ; 75006 PARIS
• Total cost: No data

OCTOPLUS DEVELOPMENT BV

Netherlands

• EU contribution: No data
• Address: Zernikedreef, 12 ; 2300 As LEIDEN
• Total cost: No data